Scorpius Holdings Files 8-K on Financials
Ticker: SCPX · Form: 8-K · Filed: May 13, 2024 · CIK: 1476963
| Field | Detail |
|---|---|
| Company | Scorpius Holdings, Inc. (SCPX) |
| Form Type | 8-K |
| Filed Date | May 13, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0002, $4.0 million, $5.0 million, $3.8 million, $5.1 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, company-update
Related Tickers: SCPX
TL;DR
SCPX filed an 8-K updating financials - check for details.
AI Summary
Scorpius Holdings, Inc. filed an 8-K on May 13, 2024, reporting on its Results of Operations and Financial Condition. The company, formerly known as NightHawk Biosciences, Inc. and HEAT BIOLOGICS, INC., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector. The filing does not contain specific financial figures or operational details beyond its classification and historical name changes.
Why It Matters
This 8-K filing indicates Scorpius Holdings, Inc. is providing an update on its financial condition, which is crucial for investors to assess the company's performance and stability.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting financial condition and does not contain immediately alarming information.
Key Players & Entities
- Scorpius Holdings, Inc. (company) — Registrant
- May 13, 2024 (date) — Date of Report
- NightHawk Biosciences, Inc. (company) — Former Company Name
- HEAT BIOLOGICS, INC. (company) — Former Company Name
- 2834 (industry_code) — Standard Industrial Classification (Pharmaceutical Preparations)
FAQ
What specific financial results or operational updates are being reported by Scorpius Holdings, Inc. in this 8-K?
The provided text for the 8-K filing indicates it is related to 'Results of Operations and Financial Condition' but does not detail the specific financial figures or operational updates within this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 13, 2024.
What were Scorpius Holdings, Inc.'s previous names?
Scorpius Holdings, Inc. was formerly known as NightHawk Biosciences, Inc. and prior to that, HEAT BIOLOGICS, INC.
In which state is Scorpius Holdings, Inc. incorporated?
Scorpius Holdings, Inc. is incorporated in Delaware.
What is the principal executive address of Scorpius Holdings, Inc.?
The principal executive address of Scorpius Holdings, Inc. is 627 Davis Drive, Suite 300, Morrisville, North Carolina 27560.
Filing Stats: 591 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2024-05-13 06:26:30
Key Financial Figures
- $0.0002 — nge on which registered Common Stock, $0.0002 par value per share SCPX NYSE America
- $4.0 million — "Company") expects to recognize between $4.0 million and $5.0 million of revenue. The Compan
- $5.0 million — s to recognize between $4.0 million and $5.0 million of revenue. The Company expects its ope
- $3.8 million — xpects its operating loss to be between $3.8 million and $5.1 million and net loss before in
- $5.1 million — ing loss to be between $3.8 million and $5.1 million and net loss before income taxes from c
- $5.3 million — erations to be between $4.0 million and $5.3 million. At March 31, 2024 the Company's cash a
- $1.7 million — hort-term investments was approximately $1.7 million. The estimates of revenue, operating l
Filing Documents
- scpx_8k.htm (8-K) — 26KB
- 0001079973-24-000680.txt ( ) — 237KB
- scpx-20240513.xsd (EX-101.SCH) — 3KB
- scpx-20240513_def.xml (EX-101.DEF) — 26KB
- scpx-20240513_lab.xml (EX-101.LAB) — 36KB
- scpx-20240513_pre.xml (EX-101.PRE) — 25KB
- scpx_8k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: May 13, 2024 SCORPIUS HOLDINGS, INC. By: /s/ Jeffrey Wolf Name: Jeffrey Wolf Title: Chairman, President and Chief Executive Officer